Jim Cramer’s Thoughts on These 10 Stocks

5. IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Number of Hedge Fund Holders: 51

Answering a caller’s query about IDEXX Laboratories, Inc. (NASDAQ:IDXX) during the lightning round, Cramer said:

“Oh, IDEXX. All right, look, this one’s had too big a run. I’m not there for it. I’m sorry, 42 times earnings is a lot to pay for that kind of company. I’m not, I just can’t get my arms around it.”

IDEXX Laboratories (NASDAQ:IDXX) develops and supplies diagnostic tools and services used in animal health, food production, and water quality testing. Baron Focused Growth Fund stated the following regarding IDEXX Laboratories, Inc. (NASDAQ:IDXX) in its Q1 2025 investor letter:

“The performance of many stocks in the Health Care sector can change quickly due to exogenous events or binary outcomes (e.g., biotechnology and pharmaceuticals). As a result, we do not invest a large amount in these stocks in this focused portfolio. In Health Care, we invest in competitively advantaged companies that are leaders in their industries such as IDEXX Laboratories, Inc. (NASDAQ:IDXX), the leading provider of diagnostics to the veterinary industry and who is benefiting from the increase in pets that people acquired during the COVID pandemic, especially as these pets age. The Fund is further diversified by investments in businesses at different stages of growth and development.”